BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas will join the panel, "How the Other Half Lives: What's Happening in Venture and Why it Matters" at the BIO CEO Investor conference.
News | 02. 11. 2013
Art Pappas will join the panel, "How the Other Half Lives: What's Happening in Venture and Why it Matters" at the BIO CEO Investor conference.
